首页> 外国专利> Self assembling Amphiphilic Polymers as antiviral agents for the Prevention of infection in an animal by a virus like the flu or Rabies

Self assembling Amphiphilic Polymers as antiviral agents for the Prevention of infection in an animal by a virus like the flu or Rabies

机译:自组装的两亲聚合物作为抗病毒剂,可防止动物被流感或狂犬病等病毒感染

摘要

Claim 1: a method for the Treatment or prevention of an infection of an animal by a virus, which comprises administering to the animal a combined Polymer which is essentially the structure of formula (1), comprising a Skeleton formed by the remains of the Alternating S points b and the ramifications of Hydrophilic Polymer blocks,Soluble in water; and has Hydrophobic Side Chains and Z c ligands attached to the remains of the Branch Points, where each side chain C is selected independently from the group consisting of linear or branched hydrocarbons C6 30 optionally substituted with one or More Hydrophilic substituents.Polycyclic hydrocarbons C6 30 optionally substituted with one or more Hydrophilic substituents, and amino acidsEach ligand peptides and Hydrophobic Polymer; Z is regardless a ligand that has specific binding Affinity for the surface of said virus; s is a link or a Spacer Rest; The value of n varies from 3 to about 100; the average value of P varies from 1 to 4; and The average value of R varies from 1 to 8.Claim 2: The Method according to claim 1, wherein at least one ligand is acetilneuramu00ednico acid n - or one of its derivatives.Claim 3: The Method according to claim 2, wherein Said ligand selected from the group consisting acetilneuramu00ednico acid n -, beta methylglucoside acid and 4 - neuramu00ednico acid guanidine didesoxi 2.3 - 2.4 - - - - - acetilneuramu00ednico Dehydrated.Claim 3: The Method according to claim 1, wherein at least one ligand is an Antibody or Antibody fragment that has specific binding Affinity for the surface of the virus. Claim 1: The Method according to claim 4, wherein Said ligand is a fragment F (AB ') 2 derived from human IgG antirabies immune globin.Claim 2: The Method according to claim 1, wherein at least one ligand z is a Peptide selected from the group consisting kdyrgwkhwvyytc, kdyrgwkowvyytc, kgwkhwvyc (NH2) and kgwkowvyc (NH2).
机译:1。一种用于治疗或预防动物被病毒感染的方法,该方法包括向该动物施用一种基本上为式(1)结构的组合聚合物,该聚合物包含由交变残骸形成的骨架。 S点b和亲水性聚合物嵌段的衍生物,溶于水;且具有在分支点的其余部分上连接的疏水侧链和Z c配体,其中每个侧链C独立选自直链或支链烃C6 30,可选地被一个或多个亲水取代基取代。多环烃C6 30任选地被一个或多个亲水取代基和氨基酸取代每个配体肽和疏水聚合物; Z无论是对所述病毒表面具有特异性结合亲和力的配体;或s是一个链接或一个空格符; n的值从3到大约100不等; P的平均值为1至4; 2.根据权利要求1所述的方法,其中,至少一种配体是乙炔神经酰胺/癸二酸n-或其衍生物之一。3.根据权利要求2所述的方法,其中,R的平均值为1〜8。 3.根据权利要求1所述的方法,其特征在于,所述配体选自乙酰胺神经酰胺,β-甲基葡糖苷酸和4-神经酰胺乙氧基2.3-2.4 ---乙炔神经酰胺脱水。其中至少一个配体是对病毒表面具有特异性结合亲和力的抗体或抗体片段。权利要求1:根据权利要求4的方法,其中所述配体是衍生自人IgG抗狂犬病免疫球蛋白的片段F(AB′)2。2:根据权利要求1的方法,其中至少一个配体z是选择的肽选自kdyrgwkhwvyytc,kdyrgwkowvyytc,kgwkhwvyc(NH2)和kgwkowvyc(NH2)。

著录项

  • 公开/公告号AR068797A1

    专利类型

  • 公开/公告日2009-12-09

    原文格式PDF

  • 申请/专利权人 ALLEXCELL INC;

    申请/专利号AR2008P103213

  • 申请日2008-07-24

  • 分类号A61K39/42;A61K31/74;A61P31/12;C07K7/04;C07K16/08;

  • 国家 AR

  • 入库时间 2022-08-21 18:47:33

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号